Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Post by MustangSalleyon Jun 08, 2022 12:20am
313 Views
Post# 34739118

Meanwhile Verte 's IR department

Meanwhile Verte 's IR departmentSpins lacklustre trial results into positive momentum for its sp. The entire IR team should be fired. It's time for Spillup to go and BOD. This is on them. He cried wolf for over one year about a pharma deal.... no momentum in sp. Cried wolf for 6 months for Tsx uplisting as reason for no institutional buyers... no momentum in sp. Now great results.... no momentum . No catalyst upcoming except lots of warrants to be exercised by end of summer. Does anybody really think management is capable of finding a buyer for 20 million shares? https://www.investors.com/research/ibd-stock-of-the-day/vrtx-stock-eyes-breakout-as-tech-leader-makes-a-move-in-diabetes/
<< Previous
Bullboard Posts
Next >>